NO922332D0 - Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer - Google Patents

Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer

Info

Publication number: NO922332D0
Authority: NO; Norway
Prior art keywords: cell lines; cross; humaneb; dependent; procedure
Prior art date: 1989-12-14

Application number

NO922332A

Other languages

English (en)

Other versions

NO922332L (no

Inventor

Jacques Banchereau

Francoise Rousset

Original Assignee

Schering Plough Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-14

Filing date

1992-06-12

Publication date

1992-06-12

1992-06-12 Application filed by Schering Plough Corp filed Critical Schering Plough Corp

1992-06-12 Publication of NO922332D0 publication Critical patent/NO922332D0/no

1992-06-12 Publication of NO922332L publication Critical patent/NO922332L/no

Links

238000000034 method Methods 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title 1
210000003719 b-lymphocyte Anatomy 0.000 abstract 2
239000003431 cross linking reagent Substances 0.000 abstract 2
238000012258 culturing Methods 0.000 abstract 2
230000007774 longterm Effects 0.000 abstract 2
108010063916 CD40 Antigens Proteins 0.000 abstract 1
101150013553 CD40 gene Proteins 0.000 abstract 1
108060003951 Immunoglobulin Proteins 0.000 abstract 1
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000004132 cross linking Methods 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
102000018358 immunoglobulin Human genes 0.000 abstract 1
210000004962 mammalian cell Anatomy 0.000 abstract 1
230000003362 replicative effect Effects 0.000 abstract 1
230000000284 resting effect Effects 0.000 abstract 1
230000003248 secreting effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/52—CD40, CD40-ligand (CD154)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Control Of El Displays (AREA)
Photosensitive Polymer And Photoresist Processing (AREA)
Curing Cements, Concrete, And Artificial Stone (AREA)
Silicon Polymers (AREA)
Materials For Medical Uses (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Light Receiving Elements (AREA)

NO92922332A 1989-12-14 1992-06-12 Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer NO922332L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP19890403491 EP0434879A1 (en)	1989-12-14	1989-12-14	Method of making factor dependent human B cell lines
PCT/EP1990/002195 WO1991009115A1 (en)	1989-12-14	1990-12-13	Method of making factor-dependent human b cell lines

Publications (2)

Publication Number	Publication Date
NO922332D0 true NO922332D0 (no)	1992-06-12
NO922332L NO922332L (no)	1992-06-12

Family

ID=8203014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO92922332A NO922332L (no)	1989-12-14	1992-06-12	Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer

Country Status (16)

Country	Link
EP (2)	EP0434879A1 (no)
JP (1)	JPH0789910B2 (no)
AT (1)	ATE135041T1 (no)
AU (1)	AU655759B2 (no)
CA (1)	CA2071886A1 (no)
DE (1)	DE69025772T2 (no)
ES (1)	ES2084146T3 (no)
FI (1)	FI922655A0 (no)
IE (1)	IE904498A1 (no)
IL (1)	IL96639A0 (no)
MY (1)	MY106561A (no)
NO (1)	NO922332L (no)
NZ (1)	NZ236425A (no)
OA (1)	OA09701A (no)
WO (1)	WO1991009115A1 (no)
ZA (1)	ZA909778B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5874082A (en) *	1992-07-09	1999-02-23	Chiron Corporation	Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
US5397703A (en)	1992-07-09	1995-03-14	Cetus Oncology Corporation	Method for generation of antibodies to cell surface molecules
AU5098493A (en) *	1992-08-21	1994-03-15	Schering Corporation	Cd40 ligand, anti cd40 antibodies, and soluble cd40
EP0619323A1 (en) *	1993-04-09	1994-10-12	Schering-Plough	Human monoclonal antibodies and processes and materials for making such antibodies
EP0659766A1 (en) *	1993-11-23	1995-06-28	Schering-Plough	Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
US5959085A (en) *	1993-11-23	1999-09-28	Schering Corporation	Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
ES2251719T3 (es)	1994-04-28	2006-05-01	Boehringer Ingelheim Pharmaceuticals Inc.	Metodos para la proliferacion y diferenciacion de celulas b y su empleo.
US6465251B1 (en) *	1996-11-13	2002-10-15	Dana-Farber Cancer Institute, Inc.	Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
WO1999022008A1 (en) *	1997-10-27	1999-05-06	Sumitomo Electric Industries, Ltd.	Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody
US7063845B2 (en)	2000-04-28	2006-06-20	Gemini Science, Inc.	Human anti-CD40 antibodies
JP4202127B2 (ja)	2000-10-02	2008-12-24	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	アンタゴニスト抗ｃｄ４０抗体を用いるｂ細胞悪性腫瘍の治療方法
PT1391464E (pt)	2001-04-27	2007-11-15	Kirin Pharma Kk	Anticorpo monoclonal anti-cd40
GB2398783A (en)	2003-02-26	2004-09-01	Antonio Lanzavecchia	A method for producing immortalised human B memory lymphocytes
WO2004076677A2 (en) *	2003-02-26	2004-09-10	Institute For Research In Biomedicine	Monoclonal antibody production by ebv transformation of b cells
DK1915620T3 (da)	2005-08-02	2010-10-04	Xbiotech Inc	Diagnose, behandling og prævention af vaskulære sygdomme ved hjælp af IL-1alpha-autoantistoffer
PL2464664T3 (pl)	2009-08-13	2016-02-29	Crucell Holland Bv	Przeciwciała przeciwko ludzkiemu syncytialnemu wirusowi oddechowemu (RSV) i sposoby zastosowania
EP2316920A1 (en)	2009-10-30	2011-05-04	BioNTech AG	Clonal expansion of B cells
PH12012502244A1 (en)	2010-07-09	2016-09-30	Crucell Holland Bv	Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
WO2013000982A1 (en)	2011-06-27	2013-01-03	Vivalis	Method for screening cells

1989
- 1989-12-14 EP EP19890403491 patent/EP0434879A1/en not_active Withdrawn
1990
- 1990-12-05 ZA ZA909778A patent/ZA909778B/xx unknown
- 1990-12-11 MY MYPI90002163A patent/MY106561A/en unknown
- 1990-12-11 NZ NZ236425A patent/NZ236425A/xx unknown
- 1990-12-12 IL IL96639A patent/IL96639A0/xx unknown
- 1990-12-13 IE IE449890A patent/IE904498A1/en unknown
- 1990-12-13 WO PCT/EP1990/002195 patent/WO1991009115A1/en not_active Ceased
- 1990-12-13 JP JP3500964A patent/JPH0789910B2/ja not_active Expired - Lifetime
- 1990-12-13 AU AU69017/91A patent/AU655759B2/en not_active Ceased
- 1990-12-13 ES ES91900209T patent/ES2084146T3/es not_active Expired - Lifetime
- 1990-12-13 EP EP91900209A patent/EP0505397B1/en not_active Expired - Lifetime
- 1990-12-13 FI FI922655A patent/FI922655A0/fi not_active Application Discontinuation
- 1990-12-13 DE DE69025772T patent/DE69025772T2/de not_active Expired - Fee Related
- 1990-12-13 AT AT91900209T patent/ATE135041T1/de not_active IP Right Cessation
- 1990-12-13 CA CA002071886A patent/CA2071886A1/en not_active Abandoned
1992
- 1992-06-04 OA OA60226A patent/OA09701A/en unknown
- 1992-06-12 NO NO92922332A patent/NO922332L/no unknown

Also Published As

Publication number	Publication date
FI922655A7 (fi)	1992-06-09
ES2084146T3 (es)	1996-05-01
CA2071886A1 (en)	1991-06-15
NZ236425A (en)	1993-02-25
WO1991009115A1 (en)	1991-06-27
ATE135041T1 (de)	1996-03-15
IL96639A0 (en)	1991-09-16
DE69025772D1 (de)	1996-04-11
MY106561A (en)	1995-06-30
IE904498A1 (en)	1991-06-19
OA09701A (en)	1993-08-30
ZA909778B (en)	1991-10-30
FI922655A0 (fi)	1992-06-09
EP0505397A1 (en)	1992-09-30
JPH0789910B2 (ja)	1995-10-04
DE69025772T2 (de)	1997-02-06
AU655759B2 (en)	1995-01-12
JPH05503214A (ja)	1993-06-03
EP0505397B1 (en)	1996-03-06
NO922332L (no)	1992-06-12
AU6901791A (en)	1991-07-18
EP0434879A1 (en)	1991-07-03

Publication	Publication Date	Title
NO922332D0 (no)	1992-06-12	Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer
AU2508492A (en)	1993-03-16	Sirs vaccine and diagnosis method
AU544792B2 (en)	1985-06-13	Monoclonal antibodies to human helper t cells
JPS6447378A (en)	1989-02-21	Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
PH16642A (en)	1983-12-06	Complement-fixing monoclonal antibody to human t cells,and methods of preparing same
GB2128630A (en)	1984-05-02	Method of affinity purification employing monoclonal antibodies
ATE71411T1 (de)	1992-01-15	Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
ATE67313T1 (de)	1991-09-15	Nachweis von menschlichem cytomegalovirusspezifischem igm.
DE59209079D1 (de)	1998-02-05	Monoklonale Antikörper gegen humane Pankreas-Inselzellen
AU564575B2 (en)	1987-08-20	Polyvalent endotoxin specific antibodies
AU635243B2 (en)	1993-03-18	Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
JPS6488367A (en)	1989-04-03	Immobilized antibody
DE69015230D1 (de)	1995-02-02	Antikörper gegen menschliches Sperma, ihre Herstellung und Anwendung.
EP0323802A3 (en)	1989-07-26	Monoclonal antibodies against, and cell surface antigen of, lung carcinoma
ATE132267T1 (de)	1996-01-15	Immuntest unter verwendung von antigenen, produziert in heterologen organismen
DE3580524D1 (de)	1990-12-20	Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
NO852058L (no)	1985-11-26	Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
JPS6459068A (en)	1989-03-06	Method for measuring human thyroxin binding globulin
EP0089771A3 (en)	1984-07-11	Atcc hb8116 and its monoclonal anti-h-y antibody, hyclonalan
MX9703956A (es)	1997-09-30	Genes purificados que codifican antigenos de superficie de celulas de mamiferos; proteinas y anticuerpos.
SU1529724A1 (ru)	1999-04-27	Штамм культивируемых гибридных клеток животного mus musculus - продуцент моноклонального антитела к термостабильному поверхностному антигену возбудителя сапа
SU1398393A1 (ru)	1999-04-27	Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к микобактериям туберкулеза
IT8821547A0 (it)	1988-07-29	Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.